| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study J Lammer, K Malagari, T Vogl, F Pilleul, A Denys, A Watkinson, M Pitton, ... Cardiovascular and interventional radiology 33, 41-52, 2010 | 1804 | 2010 |
| Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis P Schenk, M Schöniger-Hekele, V Fuhrmann, C Madl, G Silberhumer, ... Gastroenterology 125 (4), 1042-1052, 2003 | 466 | 2003 |
| Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences P Schenk, V Fuhrmann, C Madl, G Funk, S Lehr, O Kandel, C Müller Gut 51 (6), 853-859, 2002 | 453 | 2002 |
| The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma W Sieghart, F Hucke, M Pinter, I Graziadei, W Vogel, C Müller, H Heinzl, ... Hepatology 57 (6), 2261-2273, 2013 | 377 | 2013 |
| Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients N von Ahsen, C Müller, S Serke, U Frei, KU Eckardt Critical care medicine 29 (9), S141-S150, 2001 | 330 | 2001 |
| Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-γ in patients with inoperable hepatocellular carcinoma W Reinisch, M Holub, A Katz, A Herneth, C Lichtenberger, ... Journal of Immunotherapy 25 (6), 489-499, 2002 | 304 | 2002 |
| Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion Canadian-European Randomized Control Trial Group Diabetes 37 (11), 1574-1582, 1988 | 297 | 1988 |
| Hepatocellular carcinoma in Central Europe: prognostic features and survival M Schöniger-Hekele, C Müller, M Kutilek, C Oesterreicher, P Ferenci, ... Gut 48 (1), 103-109, 2001 | 288 | 2001 |
| Methylene blue improves the hepatopulmonary syndrome P Schenk, C Madl, S Rezaie-Majd, S Lehr, C Müller Annals of Internal Medicine 133 (9), 701-706, 2000 | 280 | 2000 |
| Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT: Correlation with clinical findings and comparison with multiple … T Brücke, S Asenbaum, W Pirker, S Djamshidian, S Wenger, C Wöber, ... Advances in Research on Neurodegeneration: Volume 5, 9-24, 1997 | 272 | 1997 |
| Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders T Brücke, I Podreka, P Angelberger, S Wenger, A Topitz, B Küfferle, ... Journal of Cerebral Blood Flow & Metabolism 11 (2), 220-228, 1991 | 263 | 1991 |
| Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib M Pinter, F Hucke, I Graziadei, W Vogel, A Maieron, R Königsberg, ... Radiology 263 (2), 590-599, 2012 | 222 | 2012 |
| Tropheryma whipplei infection and Whipple's disease T Marth, V Moos, C Müller, F Biagi, T Schneider The Lancet Infectious Diseases 16 (3), e13-e22, 2016 | 186 | 2016 |
| Tropheryma whipplei in the Environment: Survey of Sewage Plant Influxes and Sewage Plant Workers M Schöniger-Hekele, D Petermann, B Weber, C Müller Applied and environmental microbiology 73 (6), 2033-2035, 2007 | 183 | 2007 |
| How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma F Hucke, M Pinter, I Graziadei, S Bota, W Vogel, C Müller, H Heinzl, ... Journal of hepatology 61 (6), 1287-1296, 2014 | 181 | 2014 |
| Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment U Heider, M Kaiser, C Müller, C Jakob, I Zavrski, CO Schulz, C Fleissner, ... European journal of haematology 77 (3), 233-238, 2006 | 178 | 2006 |
| HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis C Oesterreicher, J Hammer, U Koch, F Pfeffel, G Sunder-Plassmann, ... Kidney international 48 (6), 1967-1971, 1995 | 155 | 1995 |
| Prognosis of patients with hepatocellular carcinoma treated with immunotherapy–development and validation of the CRAFITY score B Scheiner, K Pomej, MM Kirstein, F Hucke, F Finkelmeier, O Waidmann, ... Journal of hepatology 76 (2), 353-363, 2022 | 153 | 2022 |
| The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE F Hucke, W Sieghart, M Pinter, I Graziadei, W Vogel, C Müller, H Heinzl, ... Journal of Hepatology 60 (1), 118-126, 2014 | 151 | 2014 |
| Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a H Hofer, HC Bankl, F Wrba, P Steindl-Munda, M Peck-Radosavljevic, ... Official journal of the American College of Gastroenterology| ACG 97 (11 …, 2002 | 151 | 2002 |
